Cargando…
A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy
PURPOSE: The aim of this study was to evaluate the long-term treatment outcome and major complication rates of abdominal sacrocolpopexy (ASC). MATERIALS AND METHODS: This retrospective study included 57 Korean women who underwent ASC with mesh for symptomatic uterine or vault prolapse and attended f...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796408/ https://www.ncbi.nlm.nih.gov/pubmed/20046422 http://dx.doi.org/10.3349/ymj.2009.50.6.807 |
_version_ | 1782175528240807936 |
---|---|
author | Jeon, Myung Jae Moon, Yeo Jung Jung, Hyun Joo Lim, Kyung Jin Yang, Hyo In Kim, Sei Kwang Bai, Sang Wook |
author_facet | Jeon, Myung Jae Moon, Yeo Jung Jung, Hyun Joo Lim, Kyung Jin Yang, Hyo In Kim, Sei Kwang Bai, Sang Wook |
author_sort | Jeon, Myung Jae |
collection | PubMed |
description | PURPOSE: The aim of this study was to evaluate the long-term treatment outcome and major complication rates of abdominal sacrocolpopexy (ASC). MATERIALS AND METHODS: This retrospective study included 57 Korean women who underwent ASC with mesh for symptomatic uterine or vault prolapse and attended follow-up visits for at least 5 years. Forty-seven women with urodynamic stress incontinence concomitantly received a modified Burch colposuspension. The long-term anatomical and functional outcomes and complication rates were assessed. RESULTS: The median follow-up was 66 months (range 60-108). Overall anatomical success rates (no recurrence of any prolapse ≥ stage II according to the pelvic organ prolapse-quantification system) were 86.0%. Urinary urgency and voiding dysfunction were significantly improved after surgery, however, recurrent stress urinary incontinence developed in 44.7% (21/47) of cases and half of them developed within 1-3 months post-op. Bowel function (constipation and fecal incontinence) and sexual function (sexual activity and dyspareunia) did not significantly change after surgery. Major complication requiring reoperation or intensive care developed in 12 (21.0%) cases. CONCLUSIONS: ASC provides durable pelvic support, however, it may be ineffective for alleviating pelvic floor dysfunction except for urinary urgency and voiding dysfunction, and it contains major complication risk that cannot be overlooked. |
format | Text |
id | pubmed-2796408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Yonsei University College of Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-27964082009-12-31 A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy Jeon, Myung Jae Moon, Yeo Jung Jung, Hyun Joo Lim, Kyung Jin Yang, Hyo In Kim, Sei Kwang Bai, Sang Wook Yonsei Med J Original Article PURPOSE: The aim of this study was to evaluate the long-term treatment outcome and major complication rates of abdominal sacrocolpopexy (ASC). MATERIALS AND METHODS: This retrospective study included 57 Korean women who underwent ASC with mesh for symptomatic uterine or vault prolapse and attended follow-up visits for at least 5 years. Forty-seven women with urodynamic stress incontinence concomitantly received a modified Burch colposuspension. The long-term anatomical and functional outcomes and complication rates were assessed. RESULTS: The median follow-up was 66 months (range 60-108). Overall anatomical success rates (no recurrence of any prolapse ≥ stage II according to the pelvic organ prolapse-quantification system) were 86.0%. Urinary urgency and voiding dysfunction were significantly improved after surgery, however, recurrent stress urinary incontinence developed in 44.7% (21/47) of cases and half of them developed within 1-3 months post-op. Bowel function (constipation and fecal incontinence) and sexual function (sexual activity and dyspareunia) did not significantly change after surgery. Major complication requiring reoperation or intensive care developed in 12 (21.0%) cases. CONCLUSIONS: ASC provides durable pelvic support, however, it may be ineffective for alleviating pelvic floor dysfunction except for urinary urgency and voiding dysfunction, and it contains major complication risk that cannot be overlooked. Yonsei University College of Medicine 2009-12-31 2009-12-18 /pmc/articles/PMC2796408/ /pubmed/20046422 http://dx.doi.org/10.3349/ymj.2009.50.6.807 Text en © Copyright: Yonsei University College of Medicine 2009 http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jeon, Myung Jae Moon, Yeo Jung Jung, Hyun Joo Lim, Kyung Jin Yang, Hyo In Kim, Sei Kwang Bai, Sang Wook A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy |
title | A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy |
title_full | A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy |
title_fullStr | A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy |
title_full_unstemmed | A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy |
title_short | A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy |
title_sort | long-term treatment outcome of abdominal sacrocolpopexy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796408/ https://www.ncbi.nlm.nih.gov/pubmed/20046422 http://dx.doi.org/10.3349/ymj.2009.50.6.807 |
work_keys_str_mv | AT jeonmyungjae alongtermtreatmentoutcomeofabdominalsacrocolpopexy AT moonyeojung alongtermtreatmentoutcomeofabdominalsacrocolpopexy AT junghyunjoo alongtermtreatmentoutcomeofabdominalsacrocolpopexy AT limkyungjin alongtermtreatmentoutcomeofabdominalsacrocolpopexy AT yanghyoin alongtermtreatmentoutcomeofabdominalsacrocolpopexy AT kimseikwang alongtermtreatmentoutcomeofabdominalsacrocolpopexy AT baisangwook alongtermtreatmentoutcomeofabdominalsacrocolpopexy AT jeonmyungjae longtermtreatmentoutcomeofabdominalsacrocolpopexy AT moonyeojung longtermtreatmentoutcomeofabdominalsacrocolpopexy AT junghyunjoo longtermtreatmentoutcomeofabdominalsacrocolpopexy AT limkyungjin longtermtreatmentoutcomeofabdominalsacrocolpopexy AT yanghyoin longtermtreatmentoutcomeofabdominalsacrocolpopexy AT kimseikwang longtermtreatmentoutcomeofabdominalsacrocolpopexy AT baisangwook longtermtreatmentoutcomeofabdominalsacrocolpopexy |